Scioderm

Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3
Xconomy
Wed, 09/13/17 - 09:39 am
Amicus
Scioderm
clinical trials
epidermolysis bullosa
Drug developer gets Scioderm FDA cash to work on orphan disease drug
Bizjournals.com
Tue, 09/22/15 - 09:51 am
Scioderm
FDA
orphan drugs
epidermolysis bullosa
Zorblisa
Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline
TheStreet.com
Mon, 08/31/15 - 08:23 am
Amicus Therapeutics
Scioderm
M&A
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wed, 09/25/13 - 01:04 pm
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra